OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis
Hedy Maagdenberg, Natanja Oosterom, Jolanda Zanen, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 161, pp. 103312-103312
Closed Access | Times Cited: 21
Hedy Maagdenberg, Natanja Oosterom, Jolanda Zanen, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 161, pp. 103312-103312
Closed Access | Times Cited: 21
Showing 21 citing articles:
Paeonol repurposing for cancer therapy: From mechanism to clinical translation
Ying Wang, BING-SHU LI, Zihui Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115277-115277
Open Access | Times Cited: 14
Ying Wang, BING-SHU LI, Zihui Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115277-115277
Open Access | Times Cited: 14
Linc00312 Single Nucleotide Polymorphism as Biomarker for Chemoradiotherapy Induced Hematotoxicity in Nasopharyngeal Carcinoma Patients
Zhen Guo, Ya-Jing Wang, Binsheng He, et al.
Disease Markers (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 22
Zhen Guo, Ya-Jing Wang, Binsheng He, et al.
Disease Markers (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 22
Prognostic impact of clinical and genetic factors on delayed elimination of methotrexate in children with acute lymphoblastic leukemia
О. D. Gurieva, Marina I. Savelyevа, Т. Т. Валиев, et al.
Pharmacokinetics and Pharmacodynamics (2025), Iss. 4, pp. 29-38
Open Access
О. D. Gurieva, Marina I. Savelyevа, Т. Т. Валиев, et al.
Pharmacokinetics and Pharmacodynamics (2025), Iss. 4, pp. 29-38
Open Access
The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis
Zaiwei Song, Yang Hu, Shuang Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 22
Zaiwei Song, Yang Hu, Shuang Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 22
Risk factors associated with high-dose methotrexate induced toxicities
Wenshu Li, Jiayi Mo, Zhilin Yang, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 4, pp. 263-274
Closed Access | Times Cited: 2
Wenshu Li, Jiayi Mo, Zhilin Yang, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 4, pp. 263-274
Closed Access | Times Cited: 2
Characterization and application of targeted MnO2/CS@ALA-MTX nano-radiosensitizers for boosting X-ray radiotherapy of brain tumors
Yasin Ayyami, Masoumeh Dastgir, Marjan Ghorbani, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 692, pp. 133975-133975
Closed Access | Times Cited: 2
Yasin Ayyami, Masoumeh Dastgir, Marjan Ghorbani, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 692, pp. 133975-133975
Closed Access | Times Cited: 2
Oral Mucositis in Children with Cancer in Southeast of Iran: A Single Center Study
Ghasem Miri‐Aliabad, Zahra Ghadimi, Behnam Soltani, et al.
Zahedan Journal of Research in Medical Sciences (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Ghasem Miri‐Aliabad, Zahra Ghadimi, Behnam Soltani, et al.
Zahedan Journal of Research in Medical Sciences (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies
Jian Han, Lu Liu, Meng Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10
Jian Han, Lu Liu, Meng Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10
MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment
Wenchao Zhang, Zhongyue Liu, Zhimin Yang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Wenchao Zhang, Zhongyue Liu, Zhimin Yang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia
О. D. Gurieva, Marina I. Savelyevа, Т. Т. Валиев, et al.
Drug Metabolism and Personalized Therapy (2023) Vol. 38, Iss. 4, pp. 349-357
Closed Access | Times Cited: 3
О. D. Gurieva, Marina I. Savelyevа, Т. Т. Валиев, et al.
Drug Metabolism and Personalized Therapy (2023) Vol. 38, Iss. 4, pp. 349-357
Closed Access | Times Cited: 3
Role of pharmacogenetic factors in the development of side effects of methotrexate in the treatment of malignant tumors: A review
Т. Т. Валиев, В. В. Семенова, A. Yu. Ikonnikova, et al.
Journal of Modern Oncology (2021) Vol. 23, Iss. 4, pp. 622-627
Open Access | Times Cited: 4
Т. Т. Валиев, В. В. Семенова, A. Yu. Ikonnikova, et al.
Journal of Modern Oncology (2021) Vol. 23, Iss. 4, pp. 622-627
Open Access | Times Cited: 4
An interactive dose optimizer based on population pharmacokinetic study to guide dosing of methotrexate in Chinese patients with osteosarcoma
Yanjie Zhang, Xiemin Qi, Xiaohui Huang, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 5, pp. 733-745
Closed Access
Yanjie Zhang, Xiemin Qi, Xiaohui Huang, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 5, pp. 733-745
Closed Access
Genetic Variants Influence the Severity of Oral Mucositis in Pediatric Osteosarcoma Patients
Renata de Almeida Zieger, Mariana Rodrigues Botton, Marina Curra, et al.
Oral Diseases (2024)
Closed Access
Renata de Almeida Zieger, Mariana Rodrigues Botton, Marina Curra, et al.
Oral Diseases (2024)
Closed Access
Prophylactic trimethoprim-sulfamethoxazole is safe in adult patients with primary central nervous system lymphoma receiving high-dose methotrexate
Qinxia Xu, Ziran Li, Tianling Ding, et al.
Annals of Hematology (2024)
Closed Access
Qinxia Xu, Ziran Li, Tianling Ding, et al.
Annals of Hematology (2024)
Closed Access
